Department of Nephrology, Hannover Medical School, Hannover, Germany.
Peter L. Reichertz Institute for Medical Informatics of TU Braunschweig and Hannover Medical School, Braunschweig and Hannover, Germany.
Transplantation. 2020 May;104(5):1095-1107. doi: 10.1097/TP.0000000000002922.
Identification of the relevant factors for death can improve patient's individual risk assessment and decision making. A well-documented patient cohort (n = 892) in a renal transplant program with protocol biopsies was used to establish multivariable models for risk assessment at 3 and 12 months posttransplantation by random survival forest analysis.
Patients transplanted between 2000 and 2007 were observed for up to 11 years. Loss to follow-up was negligible (n = 15). A total of 2251 protocol biopsies and 1214 biopsies for cause were performed. All rejections and clinical borderline rejections in protocol biopsies were treated.
Ten-year patient survival was 78%, with inferior survival of patients with graft loss. Using all pre- and posttransplant variables until 3 and 12 months (n = 65), the obtained models showed good performance to predict death (concordance index: 0.77-0.78). Validation with a separate cohort of patients (n = 349) showed a concordance index of 0.76 and good discrimination of risks by the models, despite substantial differences in clinical variables. Random survival forest analysis produced robust models over a wide range of parameter settings. Besides well-established risk factors like age, cardiovascular disease, type 2 diabetes, and graft function, posttransplant urinary tract infection and rejection treatment were important factors. Urinary tract infection and rejection treatment were not specifically associated with death due to infection or malignancy but correlated strongly with inferior graft function and graft loss.
The established models indicate the important areas that need special attention in the care of renal transplant patients, particularly modifiable factors like graft rejection and urinary tract infection.
识别相关死亡因素可以改善患者的个体风险评估和决策。本研究使用了一项肾移植项目中经过详细记录的患者队列(n=892),通过随机生存森林分析建立了移植后 3 个月和 12 个月的多变量风险评估模型。
2000 年至 2007 年间接受移植的患者接受了长达 11 年的随访,失访率可忽略不计(n=15)。共进行了 2251 次方案活检和 1214 次因原因进行的活检。所有移植后排斥反应和临床边界性排斥反应均进行了治疗。
10 年患者生存率为 78%,移植失败患者的生存率较低。使用移植前和移植后所有变量直至 3 个月和 12 个月(n=65),所获得的模型在预测死亡方面表现良好(一致性指数:0.77-0.78)。使用另一批患者队列(n=349)进行验证,模型的一致性指数为 0.76,且风险区分度较好,尽管临床变量存在较大差异。随机生存森林分析在广泛的参数设置范围内生成了稳健的模型。除了年龄、心血管疾病、2 型糖尿病和移植物功能等已确立的风险因素外,移植后尿路感染和排斥反应治疗也是重要因素。尿路感染和排斥反应治疗与感染或恶性肿瘤导致的死亡无关,但与移植物功能较差和移植物丢失密切相关。
所建立的模型表明,在肾移植患者的护理中需要特别关注重要领域,特别是可改变的因素,如移植物排斥和尿路感染。